Literature DB >> 34570512

Stereodivergent Nucleophilic Additions to Racemic β-Oxo Acid Derivatives: Fast Addition Outcompetes Stereoconvergence in the Archetypal Configurationally Unstable Electrophile.

Pedro De Jesús Cruz1, Evan T Crawford1, Shubin Liu1,2, Jeffrey S Johnson1.   

Abstract

Additions of carbon nucleophiles to racemic α-stereogenic β-oxo acid derivatives that deliver enantiomerically enriched tertiary alcohols are valuable, but uncommon. This article describes stereodivergent Cu-catalyzed borylative cyclizations of racemic β-oxo acid derivatives bearing tethered pro-nucleophilic olefins to deliver highly functionalized cyclopentanols containing four contiguous stereogenic centers. The reported protocol is applicable to a range of β-oxo acid derivatives, and the diastereomeric products are readily isolable by typical chromatographic techniques. α-Stereogenic-β-keto esters are typically thought to have extreme or spontaneous configurational fragility, but mechanistic studies for this system reveal an unusual scenario wherein productive catalysis occurs on the same time scale as background substrate racemization and completely outcompetes on-cycle epimerization, even under the basic conditions of the reaction.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34570512      PMCID: PMC8497423          DOI: 10.1021/jacs.1c07702

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   16.383


  37 in total

1.  Developments in asymmetric hydrogenation from an industrial perspective.

Authors:  Hideo Shimizu; Izuru Nagasaki; Kazuhiko Matsumura; Noboru Sayo; Takao Saito
Journal:  Acc Chem Res       Date:  2007-08-09       Impact factor: 22.384

2.  Copper(I)-Catalyzed Enantio- and Diastereodivergent Borylative Coupling of Styrenes and Imines.

Authors:  Taisuke Itoh; Yamato Kanzaki; Yohei Shimizu; Motomu Kanai
Journal:  Angew Chem Int Ed Engl       Date:  2018-05-30       Impact factor: 15.336

3.  Rhodium-catalyzed asymmetric formal olefination or cycloaddition: 1,3-dicarbonyl compounds reacting with 1,6-diynes or 1,6-enynes.

Authors:  Takeshi Suda; Keiichi Noguchi; Ken Tanaka
Journal:  Angew Chem Int Ed Engl       Date:  2011-04-07       Impact factor: 15.336

4.  Diphenylphosphoryl azide. A new convenient reagent for a modified Curtus reaction and for the peptide synthesis.

Authors:  T Shioiri; K Ninomiya; S Yamada
Journal:  J Am Chem Soc       Date:  1972-08-23       Impact factor: 15.419

5.  Enantio- and Diastereoselective Synthesis of Functionalized Carbocycles by Cu-Catalyzed Borylative Cyclization of Alkynes with Ketones.

Authors:  Joseph M Zanghi; Shuang Liu; Simon J Meek
Journal:  Org Lett       Date:  2019-06-14       Impact factor: 6.005

6.  Enantioselective Copper-Catalyzed Borylative Cyclization with Cyclic Imides.

Authors:  Andrew Whyte; Alexa Torelli; Bijan Mirabi; Mark Lautens
Journal:  Org Lett       Date:  2019-10-01       Impact factor: 6.005

7.  Catalytic dynamic kinetic resolutions with N-heterocyclic carbenes: asymmetric synthesis of highly substituted β-lactones.

Authors:  Daniel T Cohen; Chad C Eichman; Eric M Phillips; Emily R Zarefsky; Karl A Scheidt
Journal:  Angew Chem Int Ed Engl       Date:  2012-06-14       Impact factor: 15.336

8.  A(1,3)-strain enabled retention of chirality during bis-cyclization of beta-ketoamides: total synthesis of (-)-salinosporamide A and (-)-homosalinosporamide A.

Authors:  Henry Nguyen; Gil Ma; Daniel Romo
Journal:  Chem Commun (Camb)       Date:  2010-05-25       Impact factor: 6.222

9.  Stereoconvergent Conjugate Addition of Arylboronic Acids to α-Angelica Lactone Derivatives: Synthesis of Stereochemically Complex γ-Butyrolactones.

Authors:  Jessica A Griswold; Jeffrey S Johnson
Journal:  ACS Catal       Date:  2019-11-19       Impact factor: 13.084

10.  Efficient boron-copper additions to aryl-substituted alkenes promoted by NHC-based catalysts. enantioselective Cu-catalyzed hydroboration reactions.

Authors:  Yunmi Lee; Amir H Hoveyda
Journal:  J Am Chem Soc       Date:  2009-03-11       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.